CHẤT LƯỢNG CUỘC SỐNG CỦA NGƯỜI BỆNH SAU PHẪU THUẬT NỘI SOI BÓC NHÂN PHÌ ĐẠI LÀNH TÍNH TUYẾN TIỀN LIỆT BẰNG DAO ĐIỆN ĐƠN CỰC TẠI BỆNH VIỆN E

Abstract

Objective: To evaluate the quality of life (QoL) of patients after transurethral enucleation of benign prostatic hyperplasia (BPH) using a monopolar electrocautery system at E Hospital. Subjects and Methods: A total of 117 patients diagnosed with BPH and indicated for transurethral enucleation using monopolar electrocautery were enrolled at the Department of Urology and Andrology Surgery, E Hospital, from December 2023 to December 2024. Results: Most patients were aged 60–80 years (65.8%), with a mean age of 75.5 ± 8.4 years. The main reasons for admission were urinary retention (44.4%) and difficulty in urination (41.0%), with a mean disease duration of 8.4 years. Before surgery, all patients had severe lower urinary tract symptoms (mean IPSS 28.7 ± 5.6). Over half of the patients had PSA levels < 4 ng/ml, a mean prostate volume of 62.7 ml, and a mean post-void residual urine volume of 130 ml. At 3 months postoperatively, quality of life significantly improved across all physical, mental, and social domains (p < 0.001); the proportion of patients with good and moderate QoL increased to 83.8%, confirming the efficacy and safety of transurethral monopolar enucleation for BPH. Conclusion: Transurethral enucleation of the prostate using a monopolar electrocautery system markedly improves patients’ quality of life and is a safe and effective surgical option.